Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DPAG Postdoctoral Research Scientist Dr Sophia Malandraki-Miller took part in a pilot careers mentoring session at Oxford High School. This exciting new engagement programme is a collaboration between Medical Sciences Division researchers and Oxford Biomedical Research Centre and aims to increase awareness of the variety of careers in biomedicine.

Sophiaoutreachsharper.jpgOn Tuesday 10 March, Postdoctoral Research Scientist Dr Sophia Malandraki-Miller from the Riley Group took part in a valuable new careers mentoring opportunity piloted in collaboration between the Medical Sciences Division's Next Generation Leaders Programme and Oxford Biomedical Research Centre (BRC). This exciting new engagement programme links local schools with research and healthcare professionals within the University of Oxford and the Oxford University Hospital NHS Foundation Trust, and aims to increase awareness of the variety of careers in biomedicine.

The pilot session took place at Oxford High School with volunteers each giving around an hour of their time to speak to 15-year-old students looking at the next steps in their academic careers. Students gathered around different tables in groups of 10, with researchers moving between each group answering questions about their jobs and how they got to where they are. 

According to one of the organisers, Dr Sarah Finnegan: "We wanted to create an informal opportunity for students to learn more about careers in science and healthcare by engaging with the people working in those jobs. Students were able to ask those pressing questions such as "do you need to be good at maths?" and "what's the best thing about your job?" We hope that we motivated the students to think broadly about their career options and be inspired by the variety of careers in science and healthcare, after all you can't be what you can't see!"

Dr Malandraki-Miller is three years into her postdoctoral project with Professor Paul Riley, and works on the development of high-throughput small molecule screenings for the discovery of inducers of human epicardial cell activation, after myocardial infarction. She conducts phenotypic screens based on this model, using an automated image analysis platform utilising machine learning.

Prof Riley's group always encourages us to do outreach, and this was my first time. The session aimed to break some stereotypes in the Biomedical fields, such as around gender-bias, disability and how one can start a research career later in life. I really enjoyed it and got several questions! - Dr Malandraki-Miller

Many more volunteers from departments across the University took part, including a genetic counsellor, a radiographer, a surgeon, an anaesthetist, a science communications officer, a neuroscientist and a computer scientist.

The organising team comprised of Dr Sarah Finnegan (Nuffield Department of Clinical Neurosciences), Dr Andrés Noé, and Dr Rohan Wijesurendra and Dr Liz Ormondroyd from the Radcliffe Department of Medicine.

Similar stories

Strong performance for DPAG cardiac research at the Oxford BHF CRE Annual Symposium

Congratulations are in order for Kaitlyn Dennis, Dr Ni Li and Dr KC Park on their awards at this year's major showcase for Oxford's British Heart Foundation funded researchers.

Louisa Zolkiewski awarded the Bruce Cattanach Prize 2022

Congratulations are in order for Louisa Zolkiewski, who completed her DPhil studies this year, on being awarded the 2022 Bruce Cattanach Prize by the Genetics Society for her DPhil thesis.

Key cause of type 2 diabetes uncovered

Research led by Dr Elizabeth Haythorne and Professor Frances Ashcroft reveals high blood glucose reprograms the metabolism of pancreatic beta-cells in diabetes. They have discovered that glucose metabolites, rather than glucose itself, are key to the progression of type 2 diabetes. Glucose metabolites damage pancreatic beta-cell function, so they are unable to release enough of the hormone insulin. Reducing the rate at which glucose is metabolised, and these glucose metabolites build up, can prevent the effects of hyperglycaemia.

New Pfizer grant paves the way to a better understanding of how body fat is controlled

Professor Ana Domingos has been awarded a highly competitive independent research grant from Pfizer to discover ‘the role of Sympathetic-associated Perineurial barrier Cells in obesity’.

How desk jobs alter your brain – and why they’re so tiring

A fascinating new article on The Conversation website by DPAG's Professor Zoltán Molnár and Professor Tamas Horvath from Yale University.